UM  > Institute of Chinese Medical Sciences
Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor
Chao C.K.3; Hu H.3; Zhang L.2; Wu J.1
2016
Source PublicationJournal of Science and Technology Policy Management
ABS Journal Level1
ISSN20534639 20534620
Volume7Issue:3Pages:258-272
Abstract

Purpose: The paper aims to study how global pharmaceutical companies such as Pfizer have managed the challenges of pharmaceutical patent expiry. Design/methodology/approach: A case study method was applied. The best-selling brand drug over the past 10 years – Lipitor – was chosen as the case target. Findings: For dealing with this, this paper describes all the details of the corresponding strategies of Pfizer before and after patent expiration of Lipitor. Before patent expiry, Pfizer undertook the activities of direct-to-consumer marketing, pricing strategy for competition, legal delay and me-too drug R&D. After patent expiry, Pfizer chose to carry out continuous marketing for brand, rebate strategy, authorized generics and change to over-the-counter. In addition, diversity and globalization strategy was applied before and after patent expiry. Research limitations/implications: This research provides strong implication for managing pharmaceutical products before and after patent expiry. Practical implications: It is strongly recommended for both brand and generic drug companies to design strategies to meet the challenges of pharmaceutical patent expiry. Social implications: For the global pharmaceutical market, a conclusion can be drawn that, nowadays, the “patent cliff” is the most significant factor influencing decision-makers to consider futuristic policies. Further, it is also a considerably effective solution for reducing health-care costs for policymakers. Originality/value: This paper contributes to the field of patent expiry management in high-tech industries such as pharmaceuticals.

KeywordHealth Care Cost Lipitor Patent Expiry Pharmaceutical Industry
DOI10.1108/JSTPM-12-2015-0040
URLView the original
Indexed BySCI
Language英语
WOS Research AreaBusiness & Economics
WOS SubjectManagement
WOS IDWOS:000390761200001
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.University of Electronic Science and Technology of China
2.Sichuan University
3.Universidade de Macau
Recommended Citation
GB/T 7714
Chao C.K.,Hu H.,Zhang L.,et al. Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor[J]. Journal of Science and Technology Policy Management,2016,7(3):258-272.
APA Chao C.K.,Hu H.,Zhang L.,&Wu J..(2016).Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor.Journal of Science and Technology Policy Management,7(3),258-272.
MLA Chao C.K.,et al."Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor".Journal of Science and Technology Policy Management 7.3(2016):258-272.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Chao C.K.]'s Articles
[Hu H.]'s Articles
[Zhang L.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Chao C.K.]'s Articles
[Hu H.]'s Articles
[Zhang L.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Chao C.K.]'s Articles
[Hu H.]'s Articles
[Zhang L.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.